
    study terminated due to a safety event which rendered the risk-benefit profile in nash to no
    longer be adequately favorable
  
['nonalcoholic steatohepatitis']
['sgm-1019', 'placebo']

        Inclusion Criteria:

          -  Male or female

          -  Age 18 to 75 years, inclusive

          -  Elevated ALT

          -  F1-F3 NASH

          -  BMI ≥ 25

        Exclusion Criteria:

          -  Use of prohibited medication/supplements

          -  Poorly controlled type 2 diabetes

          -  Hepatic decompensation

          -  Chronic liver disease

          -  Planned surgeries/procedures
      